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Abstract. Lymph node involvement is the most important prognostic
factor for patients who have undergone radical surgery for colorectal
carcinoma. An accurate examination of the surgical specimens is man-
datory for the correct assessment of the lymph node status of the tumor.
The risk of understaging is particularly high for patients with tumors
classified as Dukes B (TNM stage II). The aim of this study was to
determine if a specified minimum number of lymph nodes examined per
surgical specimen could have any effect on the prognosis of patients who
had undergone radical surgery for Dukes B colorectal cancer. Between
1988 and 1995 a total of 140 patients underwent radical resection of
Dukes B colorectal cancer by the same surgeon (C.C.). The relation
between clinicopathologic variables and survival was estimated using the
Kaplan-Meier method. The Cox proportional hazard regression model
was used to identify the variables that can independently influence sur-
vival. A median of 12 lymph nodes (range 3–38) was examined per tumor
specimen. The 5-year survival rate of Dukes B patients who had had eight
or fewer lymph nodes examined after surgery was 54.9%, whereas the
survival rate for those who had had nine or more lymph nodes examined
was 79.9% (p < 0.001). Cox regression analysis identified the number of
lymph nodes as the only independent prognostic factor (p 0.01). Seventy
patients with one to four metastatic lymph nodes (Dukes C patients) who
had been operated on during the same period were included in the
survival analysis for comparison. The 5-year survival rate of the Dukes B
patients with eight or fewer lymph nodes examined was similar to that of
the 70 Dukes C patients (54.9% and 51.8%, respectively). Examination of
eight or fewer lymph nodes in Dukes B colorectal patients may be con-
sidered a high risk factor for missing positive lymph nodes in the surgical
specimens. Our results suggest that harvesting and examining a mini-
mum of nine lymph nodes per surgical specimen may be sufficient for
reliable staging of lymph node-negative tumors.
The presence or absence of lymph node metastasis is pivotal for
predicting the clinical outcome of patients who have undergone
radical surgery for colorectal carcinoma and for deciding whether
postoperative adjuvant therapy should be recommended. The
involvement of one or more lymph nodes dramatically decreases
the 5-year survival when it is compared to the absence of any
metastases in patients with tumors with the same depth of local
invasion. An accurate assessment of the pathologic status of the
tumor lymph nodes in the resected specimen is essential for
reducing the risk of understaging.
The fat-clearance technique has been shown to increase the
accuracy of lymph node harvest in surgical specimens when com-
pared with manual dissection [1–4]. More recently, immunohis-
tochemistry to cytokeratin [5–7] and genetic techniques, such as
the polymerase chain reaction (PCR) for carcinoembryonic anti-
gen (CEA) [8–10], have been proposed to identify small clusters
of cancer cells (“micrometastases”) within lymph nodes. What
constitutes an adequate, reliable conventional examination must
be defined to establish the real prognostic value of these time-
consuming, labor-intensive methods and to permit meaningful
comparisons between conventional histopathologic examinations
and any of these other techniques. An important question that
remains to be answered is the minimum number of lymph nodes
that must be harvested with the surgical specimen and examined
so that a tumor can be considered lymph node-negative. Many
factors that can lead to difficulty in establishing the minimum
number have been identified. Among them are the lack of a
constant number of lymph nodes in the various parts of the large
bowel, the extent of surgical lymphadenectomy, and the skill and
energy of the pathologist.
The risk of understaging is particularly high in patients with
tumors classified as Dukes B (i.e., tumors that extend beyond the
bowel wall with negative lymph nodes). The cancer-related mor-
tality rate of these patients may be explained in part by examining
an insufficient number of lymph nodes, which could lead to over-
looking one or more positive lymph nodes. The probability of
failing to detect the presence of positive lymph nodes may also be
increased as a consequence of the fact that most (61–77%) met-
astatic lymph nodes are less than 5 mm in diameter [6, 11]. The
aims of this study were to evaluate the clinical outcome of patients
who had undergone radical surgery for Dukes B colorectal cancer
and to determine if a specified minimum number of examinedCorrespondence to: F. Cianchi, M.D., e-mail: clin_chir_dc@cesit1.unifi.it
lymph nodes per surgical specimen could have any effect on
prognosis.
Materials and Methods
Between 1988 and 1995 a total of 301 consecutive patients under-
went radical resection of colorectal cancer by the same surgeon
(C.C.), at our operative unit. Altogether, 140 patients, 82 men
(58.6%) and 58 women (41.4%) with a median age of 67 years
(range 38–88 years) had tumors classified as Dukes B (TNM stage
II), that is, tumors that extend beyond the large bowel wall and
have no lymph node metastases. The clinical outcome of these
patients was studied retrospectively. Cases with known distant
metastases or incomplete clearance of the tumor were excluded to
avoid any factors that could interfere with the survival analysis. In
all cases, radical resection had included lymphadenectomy. For
proximal colon tumors, lymphadenectomy was extended to the
origin of the ilecolic, right colic, and middle colic arteries. For
distal colon lesions and rectal tumors, it was extended to the origin
of the inferior mesenteric artery and to the common iliac vessels
along the preaortocaval space. Total mesorectal excision was
performed in all patients with tumors of the middle and lower
rectum; a distal clearance of at least 2 cm of healthy mucosa from
the lower edge of the tumors was provided in all cases. Altogether,
39 tumors (27.8%) were located in the proximal colon (up to the
splenic flexure), 47 (33.6%) in the distal colon (up to the end of
the sigmoid colon), and 54 (38.6%) in the rectum.
Histopathology
All the surgical specimens were fixed in 10% formalin solution
and routinely processed for paraffin embedding. The number of
examined lymph nodes was ascertained by reference to the histo-
pathology report of each patient. Lymph nodes were identified in
the surgical specimens by sight and palpation. Routine histologic
examination was performed using hematoxylin and eosin staining.
Histologic processing of the specimens was the same for all pa-
tients. No special fat clearance or staining techniques were em-
ployed. Histopathologic examination was performed by one pa-
thologist (A.P.) and reviewed by another (L.M.). The following
histopathologic features were assessed for each tumor specimen:
tumor type (classified as adenocarcinoma or mucinous carcinoma
if more than 50% of the tumor volume was composed of mucin);
tumor differentiation (classified as good, moderate, or poor, ac-
cording to the World Health Organization criteria) [12]; and the
character of the invasive margin (pushing or infiltrating, according
to criteria defined by Jass et al. [13]).
Other Factors
The average duration of follow-up was 66.7 months (range 29–110
months). Patients were routinely followed up every 6 months for
the first 2 years and then once a year. Clinical assessment, serum
CEA measurement, abdominal ultrasonography, and chest radi-
ography were always carried out. The last follow-up took place in
December 1999. The survival rate of the 70 patients (41 men, 29
women; 13 tumors in the proximal colon, 21 in the distal colon, 36
in the rectum) who had been operated on during the same period
for colorectal tumors and classified as having one to four meta-
static lymph nodes (Dukes C tumors) was determined for com-
parison.
Statistical Analysis
Associations between the number of examined lymph nodes and
tumor location were evaluated using the Kruskall-Wallis test.
Clinicopathologic features of the Dukes B and Dukes C patients
were compared using the chi-square test. The relation between
clinicopathologic variables and survival was estimated using the
Kaplan-Meier method [14]. Differences among the survival curves
were tested for statistical significance with the help of the log-rank
test. The numbers of lymph nodes examined per specimen were
recorded to determine if a specific cutoff could affect clinical
outcome. The survival curves of the patients with the number of
lymph nodes above and below each cutoff value were compared.
The cutoff we considered to be the best indicator for separating
the patients with regard to survival was that which showed the
clearest rise in statistical significance (the highest chi-square). The
Cox proportional hazard regression model [15] was used to iden-
tify the clinicopathologic factors that could independently influ-
ence survival. STATA Statistical Software release 6.0 (College
Station, TX, USA) was used for all the analyses. A p value of 
0.05 was considered significant.
Results
A median number of 12 lymph nodes (range 3–38) was examined
per tumor specimen. There were no significant differences regard-
ing the number of lymph nodes identified and examined in tumors
of the proximal colon, distal colon, and rectum (median values 13,
12, and 11.5, respectively). Clinical and pathologic data regarding
the 140 Dukes B patients are summarized in Table 1. When all
140 patients were considered, the 5-year survival rate was 71.8%
(Fig. 1). Tumor location and tumor type did not have any prog-
nostic effect. The 5-year survival rate for the 72 patients (51.4%)
Table 1. Clinicopathologic features of 140 Dukes B patients.
Feature No.
Age
 67 Years 72 (51.4%)





Proximal colon 39 (27.8%)






Well differentiated 17 (14.9%)
Moderately differentiated 93 (81.6%)
Poorly differentiated 4 (3.5%)
Character of invasive margin
Pushing 36 (25.7%)
Infiltrating 104 (74.3%)
No. of lymph nodes examined
 8 55 (39.3%)
 9 85 (60.7%)
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who were  67 years was 81.6%, whereas the 5-year survival rate
for the 68 patients (48.6%) who were  67 years was 60.8% (p 
0.01). The 58 women (41.4%) had an 81.7% 5-year survival rate,
whereas the 82 men (58.6%) had a 64.5% 5-year survival rate (p
 0.01). The 5-year survival rate of the 93 patients (81.6%) with
moderately differentiated adenocarcinomas was 74.9%; it was
64.7% for the 17 patients (14.9%) with well differentiated adeno-
carcinomas and 0% for the 4 patients (3.5%) with poorly differ-
entiated adenocarcinomas (p  0.02). The character of the inva-
sive margin of the tumor was also considered: the 5-year survival
rate of the 36 patients (25.7%) with pushing tumors was 84.8%,
whereas that of the 104 patients (74.3%) with infiltrating tumors
was 68.8% (p  0.04). The number of lymph nodes thought best
to separate the Dukes B patients into subgroups with different
survival rates was eight. The 5-year survival rate of the 55 patients
(39.3%) with eight or fewer lymph nodes examined was 54.9%,
whereas the survival rate of the 85 patients (60.7%) with nine or
more lymph nodes examined was 79.9% (p  0.001) (Fig. 2). Cox
regression analysis identified the number of examined lymph
nodes as the only significant and independent prognostic factor
(Table 2).
Seventy patients with one to four metastatic lymph nodes
(Dukes C patients) who had been operated on during the same
period and by the same surgeon (C.C.) were included in the
survival analysis for comparison. A median of 10 lymph nodes
(range 2–38) was examined per tumor specimen in this group of
patients. As shown in Table 3, the age groups of the patients, the
male/female ratio, the tumor location, the tumor type, and the
character of the invasive margin were comparable in the Dukes C
patients and in the Dukes B patients with eight or fewer lymph
nodes examined. However, well and moderately differentiated
tumors were more frequent in the Dukes B patients than in the
Dukes C patients. The 5-year survival rate of the Dukes B patients
with eight or fewer examined lymph nodes was similar to that of
the Dukes C patients with one to four metastatic lymph nodes
(54.9% and 51.8%, respectively) (Fig. 3).
Discussion
Lymph node involvement is the most important prognostic factor
after radical surgery for colorectal carcinoma [16–18]. It is cur-
rently the basis for including high risk patients in adjuvant ther-
apeutic protocols.
An accurate examination of the surgical specimen is mandatory
to assess the lymph node status of the tumor correctly. All the
lymph nodes should be harvested from the surgical specimens and
examined to establish that a tumor is lymph node-negative. At
present, this goal is not practical. The aim of some recently
reported studies has been the identification of the largest quantity
of lymph nodes per specimen using various special techniques
such as fat clearance [1–4]. This method seems to increase the
number of harvested lymph nodes in the specimens significantly
and thus the accuracy of tumor staging. However, because fat
clearance is generally time-consuming and labor-intensive, it is
often not even taken into consideration during normal histopatho-
logic procedures. The fact that processing the specimens can take
up to 9 or 10 days for dehydration and defatting is its principal
drawback [11, 19].
The target of every pathologist should not be finding the max-
imum number of nodes in the specimen but, instead, examining a
definite minimum number of lymph nodes. This number should
significantly reduce the risk of overlooking one or more positive
Fig. 1. Overall survival of 140 Dukes B patients.
Fig. 2. Survival of Dukes B patients according to the number of lymph
nodes examined.







Age ( 67 vs.  67) 2.286 0.998–5.238 0.051
Gender (male vs. female) 2.244 0.971–5.185 0.058
Differentiation (poor vs. moderate
and good)
2.228 0.703–7.057 0.173
Invasive margin (infiltrating vs.
pushing)
2.858 0.943–8.660 0.063
No. of lymph nodes examined
( 8 vs.  9)
2.669 1.256–5.669 0.011
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lymph nodes. Unfortunately, this number has not yet been defin-
itively determined. There are objective difficulties that impede its
assessment. The variability in the number of lymph nodes in the
various regions of the large bowel, the extent of surgical lymph-
adenectomy, and the different statistical methods employed in
different studies are among the problems. These variables most
probably explain the lack of agreement in determining a univer-
sally valid minimum number of lymph nodes, above which there is
no risk of understaging. Scott and Grace [20] showed that 13
lymph nodes had to be examined to identify 94% of their Dukes
C tumors correctly. However, that number of lymph nodes cannot
be considered the minimum necessary to establish that a tumor is
lymph node-negative. In 1990 the Working Party Report to the
World Congress of Gastroenterology in Sydney [21] recom-
mended that a minimum of 12 lymph nodes should be recovered.
Although the paper did not state how this number was deter-
mined, it was adopted by the American Joint Committee on
Cancer and TNM Committee of the International Union against
Cancer. Hernanz et al. [22], using binomial distribution, estimated
that a minimum of six lymph nodes examined per specimen was
necessary for correct Dukes B staging. Goldstein et al. [23] and
more recently Maurel et al. [24] showed that the probability of
correctly classifying a colorectal tumor as node-positive increased
with the number of harvested lymph nodes. They also reported
that this increase had a plateau. In their two series of patients, this
plateau was reached when 17 lymph nodes in one and 18 in the
other had been examined.
Even if all these studies were carried out correctly from a
methodologic point of view, the absence of any statistical method
that could determine the probability of metastases in the remain-
ing unexamined lymph nodes in a surgical specimen remains the
major problem. We can only indirectly evaluate this probability by
analyzing the prognostic value of the number of lymph nodes
examined in a subgroup of tumors with the highest risk of missed
lymph nodes (i.e., tumors that extend beyond the bowel wall). If a
poor prognosis can be demonstrated for Dukes B patients with an
examined number of lymph nodes that is below a specified value
and this prognostic factor is independent of others, substaging is
most likely to be involved.
Caplin et al. [25] demonstrated that examination of six or fewer
lymph nodes in Dukes B patients correlated with poorer survival
when compared with examining seven or more. The mean number
of lymph nodes examined in their Dukes B patients was 9.8.
Moreover, they found a significant correlation between tumor site
and the number of lymph nodes examined. There was a higher
percentage of tumors with seven or more lymph nodes examined
for right-sided tumors than for left-sided tumors. They explained
this difference by considering the fact that right-sided resection
specimens often contain larger amounts of mesentery. Neverthe-
less, this finding could even be explained by some surgeon- or
pathologist-related factors. The low number of recovered lymph
nodes in their left-sided and rectal tumor specimens could have
been due to either inadequate extension of the mesorectal exci-
sion or to inadequate skill and energy on the part of the pathol-
ogist in locating lymph nodes by palpation. Perirectal lymph nodes
are known to be smaller than those in other regions of the large
bowel.
In our study, we harvested a median number of 12 lymph nodes.
This number corresponds to the number that previous studies had
reported when using manual dissection [1, 23, 26]. We did not find
any significant differences in the number of lymph nodes exam-
ined in the proximal, distal, and rectal tumor specimens (median
values: 13, 12, and 11.5, respectively). Moreover, all patients were
operated on by the same, experienced surgeon (C.C.). This prob-
ably eliminates the variable of surgeon-related prognostic factors
noted in previously published multicenter studies. Our results
showed that examination of eight or fewer lymph nodes was
related to a poorer prognosis when compared to examining nine
or more lymph nodes. Cox regression analysis demonstrated that
only the number of lymph nodes examined had a prognostic
significance that was independent from that of the other clinico-
pathologic factors. The negative prognostic effect of examining
eight or fewer lymph nodes in our Dukes B patients is most likely
Table 3. Comparison of clinicopathologic features of 70 Dukes C
patients and 55 Dukes B patients with  8 examined lymph nodes.
Feature
Dukes B patients







 67 Years 28 (51.0%) 36 (51.4%) NS
 67 Years 27 (49.0%) 34 (48.6%)
Gender
Male 34 (61.8%) 41 (58.6%) NS
Female 21 (38.2%) 29 (41.4%)
Tumor site
Proximal colon 9 (16.4%) 13 (18.6%) NS
Distal colon 19 (34.5%) 21 (30.0%)
Rectum 27 (49.1%) 36 (51.4%)
Tumor type
Adenocarcinoma 47 (85.4%) 65 (92.8%) NS
Mucinous 8 (14.6%) 5 (7.2%)
Tumor differentiation
Well differentiated 7 (14.9%) 0 0.005
Moderately differentiated 38 (80.9%) 62 (95.4%)
Poorly differentiated 2 (4.2%) 3 (4.6%)
Character of invasive margin
Pushing 13 (23.6%) 11 (15.7%) NS
Infiltrating 42 (76.4%) 59 (84.3%)
Fig. 3. Comparison of survival curves between Dukes B patients with  8
lymph nodes examined and Dukes C patients with 1–4 metastatic lymph
nodes.
Cianchi et al.: Lymph Node Harvest in Colorectal Cancer 387
explained by the presence of at least one unexamined metastatic
lymph node in some of the surgical specimens. Therefore, some
tumors with eight or fewer lymph nodes examined and reported as
Dukes B should have actually been considered Dukes C tumors.
This hypothesis seems to be supported by the fact that the survival
rate of the Dukes B patients with eight or fewer lymph nodes
examined is similar to that of the Dukes C patients who had been
operated on during the same period and by the same surgeon
(C.C.). However, we cannot exclude the presence of other factors
that can negatively influence the survival of this subgroup of
Dukes B patients, such as a diminished immune response, which
can lead to smaller lymph nodes and thus to a lower number of
lymph nodes identified.
Other questions must still be addressed. One of the most im-
portant ones regards the best way to identify the positive lymph
nodes among those recovered. Triple sectioning of lymph nodes,
immunohistochemistry, and genetic techniques, such as PCR,
have all been suggested. These means can identify small clusters
of cancer cells that may not be evidenced in lymph nodes when
using hematoxylin and eosin staining [6, 7, 9, 10, 27]. Although
many authors have reported some improvement in positive lymph
node harvest and thus the upstaging of tumors their results have
not always been confirmed [1, 28, 29]. The prognostic significance
of lymph nodes that bear “micrometastases” is still controversial
[5, 10, 30, 31], and the most accurate information provided by
conventional histopathologic examination should always be eval-
uated before immunohistochemical and genetic techniques are
used as the basis for clinical decisions. Recent studies have eval-
uated the feasibility and reliability of sentinel lymph node biopsy
in colorectal cancer [32–34]. These preliminary results indicate
that this procedure should not be utilized to predict lymph node
status and the extent of lymphadenectomy as it is now used for
melanoma and breast cancer surgery. However, sentinel lymph
node mapping in colorectal cancer may provide more accurate
tumor staging: the attention of the pathologist could be focused
on specific blue-stained lymph nodes in the resected specimens,
which are most likely to contain micrometastases [32].
Conclusions
Our results showed that the examination of eight or fewer lymph
nodes in Dukes B colorectal patients is related to a poorer prog-
nosis when compared to the examination of nine or more lymph
nodes. Caution must be exercised when trying to define a “golden
number” above which there is no risk of understaging. Our results
suggest that the recovery and examination of at least nine lymph
nodes per surgical specimen is sufficient to reach an acceptable
level of accuracy when staging a tumor as being lymph node-
negative. Only in those cases in which this number cannot be
reached by manual dissection should special techniques such as
fat clearance be used to improve the lymph node harvest. How-
ever, the total number of the lymph nodes examined should
always be reported and used as an adjustment variable in survival
studies and adjuvant therapy clinical trials.
Résumé. L’anvahissement ganglionnaire est le facteur pronostique le plus
important chez les patients ayant eu une chirurgie radicale pour cancer
colorectal. L’examen précis de la pièce d’exérèse est essentiel pour évaluer
l’état ganglionnaire de la tumeur. Le risque de sous-classification est
particulièrement élevé pour les patients ayant des tumeurs Dukes B
(TNM stade II). Le but de cette étude a été de déterminer si un nombre
minimal spécifique de ganglions lymphatiques examinés par pièce
chirurgicale pourrait avoir une influence sur le pronostic des patients
ayant eu une colectomie radicale pour un cancer colorectal Dukes B.
Entre 1988 et 1995, 140 patients ont eu une résection radicale pour cancer
colorectal Dukes B par le même chirurgien (C.C.). Le rapport entre les
paramètres clinico-pathologiques et la survie a été évalué par la méthode
de Kaplan-Meier. Un modèle de Cox (proportional hazard regression
model) a été utilisé pour identifier les facteurs indépendants de survie.
Une médiane de 12 ganglions lymphatiques (extrêmes 3–38) a été
examinée par pièce de résection. La survie à 5 ans des patients Dukes B
qui avaient huit ou moins ganglions lymphatiques a été de 54.9% alors
que la survie des patients qui avaient neuf ganglions ou plus a été de
79.9% (p) < 0.001). L’analyse multivarié par la méthode de Cox a identifié
comme seul facteur pronostique indépendant (p  0.01) le nombre de
ganglions. Soixante-dix patients ayant 1–4 ganglions lymphatiques
métastatiques (patients Dukes C), qui ont aussi été opérés pendant la
même période, ont été inclus dans l’analyse de survie à titre de
comparaison. La survie à 5 ans des patients Dukes B avec huit ganglions
ou moins était similaire à celle des 70 patients Dukes C (54.9% et 51.8%,
respectivement). L’examen de huit ganglions lymphatiques ou moins peut
être considérée comme un facteur de risque élevé pour ne pas détecter les
ganglions lymphatiques positifs dans la pièce chirurgicale. Nos résultats
suggèrent que de recueillir et d’examiner au moins neuf ganglions pari
pièce chirurgicale pourrait suffire pour faire un staging fiable des
tumeurs colorectales considérées à prior N-.
Resumen. La afectació de los ganglios linfáticos constituye uno de los
factores pronósticos más importantes en el devenir de os pacientes
sometidos a una resección colorrectal por cáncer. Por ello, el examen
minucioso de la pieza operatoria es obligatorio, con objeto de valorar
correctamente la afectación metastásica de los ganglios linfáticos. El
riesgo de una estadificación deficitaria (mas baja) es grande, sobre todo
en pacientes contumores clasificados como Dukes B (TNM estadio II). El
objetivo del este trabajo es determinar si se precisa examinar un número
mínimo específico de ganglios en cada espécimen operatorio, por si ello
podria modificar el pronóstico de los pacientes sometidos a cirugía
radical por un cáncer colorrectal tipo B de Dukes. Entre 1988 y 1995, 140
pacientes sufrieron una reseccion radical por un cáncer colorrectal (CC).
La relación existente entre las variables anatomoclinicas y la
superiviencia se valoró utilizando el método de Kaplain-Meier; la
regresión de Cox para identificar las variables que puedan tener alguna
ascendencia independiente sobre la supervivencia. Se examinaron un
promedio de 12 ganglios linfáticos (rango 3–38) por cada pieza tumoral
extirpada. La supervivencia a 5 años en pacientes con un Dukes B, en los
que tras cirugía pudieron examinase 8 o menos ganglios linfáticos, fue del
54.9%, mientras que la supervivencia de aquellos pacientes en los que se
pudieron examinar más de 9 ganglios linfáticos, fue del 79.9% (p < 0.001).
El análisis de regresión de Cox demostró que el número de ganglios
linfáticos es el único factor pronóstico independiente (p  0.01). 70
pacientes con 1–4 metástasis ganglionares (Dukes C) que fueron
intervenidos durante el mismo periodo de tiempo, se utilizaron con fines
comparativos en el análisis de la supervivencia. La tasa de supervivencia
en pacientes Dukes B, en los que 8 o menos ganglios linfáticos pudieron
ser analizados, fue similar a la de los 70 pacientes con un Dukes C (54.9%
y 51.8% respectivamente). El análisis histopatológico de 8 o menos
ganglios linfáticos en el cáncer colorrectal Dukes B constituye yn gran
factor de riesgo, pues propicia la no detección de ganglios linfáticos
positivos (metastásicos) en la pieza quirúrgica. Nuestros resultados
sugieren, que han de aislarse y analizarse un mínimo de 9 ganglios
linfáticos en cada espécimen quirúrgico para poder establecer una
estadificación fiable por lo que a la ausencia de adenopatías metastásicas
se refiere.
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